Shionogi completes acquisition of rights to ALS drug Radicava - ALS News Today
HealthcareFloridaDivestiture
Shionogi→Radicava rights
Apr 8, 2026
Shionogi — Acquisitions & M&A Deals
2 dealsTracking 2 M&A deals by Shionogi.
Shionogi: $2.5 Billion Acquisition Of RADICAVA Establishes Rare Disease Platform - Pulse 2.0
HealthcarePlatform
Shionogi→RADICAVA (edaravone) global rights from Tanabe Pharma
Apr 3, 2026